genOway SA (ALGEN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:genOway SA (ALGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9772
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
genOway SA (genOway) is a biotechnology company that develops genetically modified mouse, rat and cellular models for pharmaceutical companies and research institutes. The company develops several technology platforms such as safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe RNAi transgenesis. genOway provides access to its tool and consultancy services to its customers. It has a wide network of operations across Europe, Asia and North America. The company also has strategic alliances with few top pharmaceutical companies and leading research institutes. genOway is headquartered in Lyon, France.

genOway SA (ALGEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
genOway SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
genOway SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
genOway SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
genOway SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
genOway SA, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
GenOway Expands Licensing Agreement with IGBMC 10
Cellectis Enters into Licensing Agreement with genOway 11
StemCells Enters Into Licensing Agreement With genOway For Internal Ribosome Entry Site Technology 12
Acquisition 13
genOway Acquires Axenis 13
genOway SA – Key Competitors 14
genOway SA – Key Employees 15
genOway SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
genOway SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
genOway SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
genOway SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
genOway SA, Deals By Therapy Area, 2012 to YTD 2018 8
genOway SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GenOway Expands Licensing Agreement with IGBMC 10
Cellectis Enters into Licensing Agreement with genOway 11
StemCells Enters Into Licensing Agreement With genOway For Internal Ribosome Entry Site Technology 12
genOway Acquires Axenis 13
genOway SA, Key Competitors 14
genOway SA, Key Employees 15
genOway SA, Subsidiaries 16

List of Figures
genOway SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
genOway SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
genOway SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
genOway SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
genOway SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
genOway SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[genOway SA (ALGEN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Intellect Design Arena Limited:戦略・SWOT・企業財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Rezolute Inc (RZLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Rezolute Inc (Rezolute) formerly known as AntriaBio Inc, is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for the treatment of metabolic and orphan diseases. Its pipeline product portfolio includes AB101, a microsphere formulation of …
  • Danubius Hotel And Spa Private Company Limited:企業の戦略・SWOT・財務分析
    Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • W. L. Gore & Associates Inc:企業の戦略的SWOT分析
    W. L. Gore & Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Majesco
    Majesco - Strategy, SWOT and Corporate Finance Report Summary Majesco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Telkom SA SOC Limited:企業の戦略・SWOT・財務分析
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Essar Power Limited:発電所・企業SWOT分析
    Essar Power Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • PGNiG SA (PGN):企業の財務・戦略的SWOT分析
    PGNiG SA (PGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Elite Pharmaceuticals Inc (ELTP):製薬・医療:M&Aディール及び事業提携情報
    Summary Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs with Abbreviated New Drug Applications (ANDA) and branded drugs with New Drug Applica …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular Therapeutix), formerly I-Therapeutix Inc, is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammatio …
  • Asseco Business Solutions SA (ABS):企業の財務・戦略的SWOT分析
    Asseco Business Solutions SA (ABS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Oracle Corporation:企業の戦略・SWOT・財務情報
    Oracle Corporation - Strategy, SWOT and Corporate Finance Report Summary Oracle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Getinge AB (GETI B):企業の財務・戦略的SWOT分析
    Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • NanoString Technologies Inc (NSTG):製薬・医療:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Coastal Contacts Inc:医療機器:M&Aディール及び事業提携情報
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International Compagnie Generale d'Optique SA, is an online retailer that markets eye care products. The company provides products such as eyeglasses, contact lenses, sunglasses and vision care accessories, among others. It off …
  • Chevron Nigeria Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Nigeria Ltd (Chevron Nigeria) a subsidiary of Chevron Corporation is an oil and gas company that offers exploration, production and transportation of crude oil and natural gas. The company distributes products such as additives, jet fuels, base oil, chemical, fuel, lubricant, marine …
  • Aeroport Anapa:企業の戦略・SWOT・財務情報
    Aeroport Anapa - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆